FindTrial
Sign In

Evaluation of Dhoomavarti-Medicated Smoke in Improving Breathing Capacity

Formulation Development, Standardization and Clinical Evaluation of Shallakyadi Dhoomavarti on Peak Expiratory Flow Rate in Healthy Individuals - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104085
Enrollment
12
Registered
2026-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dhruvil Barvadiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals (WHO QOL 5)

Exclusion criteria

Exclusion criteria: Respiratory illness, asthma, COPD Pregnant or lactating women Allergy to herbal smoke Smokers or alcoholics Pittaj prakruti individuals

Design outcomes

Primary

MeasureTime frame
Daily uses Demonstrates Safety and improved P.E.F.R compatibility in healthy individuals.Timepoint: 1st day and 14th day follow up—

Secondary

MeasureTime frame
Improved Ayurvedic functional SymptomsTimepoint: 1st day and 14th day follow up—

Countries

India

Contacts

Public ContactDhruvil Barvadiya

Dr D Y Patil College of Ayurved and Research Centre

ketkicourses@gmail.com9823629481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026